Novartis acquired Chiron in 2006 and licensed the US aldesleukin business to Prometheus Laboratories in 2010 before global rights to Proleukin were subsequently acquired by Clinigen in 2018 and 2019. References
External links

Proleukin website
IL-2 Signaling Pathway
Rosenberg SA (June 2014). "IL-2: the first effective immunotherapy for human cancer". Journal of Immunology. 192 (12): 5451–8. doi:10.4049/jimmunol.1490019. PMC 6293462. PMID 24907378. Overview of all the structural information available in the PDB for UniProt: P60568 (Interleukin-2) at the PDBe-KB.
Diagnosis
Clinical features of myxedema coma:
Cardiovascular
Bradycardia
Bundle branch blocks
Complete heart block and arrhythmias
Cardiomegaly
Elevated diastolic blood pressure—early
Hypotension—late
Low cardiac output
Non-specific ECG findings
Pericardial effusion
Polymorphic ventricular tachycardia (torsades de pointes)
Prolonged QT interval
Respiratory
Hypoxia
Hypercapnia
Hyperventilation
Myxedema of the larynx
Pleural effusion
Gastrointestinal
Abdominal distention
Abdominal pain
Anasarca
Anorexia and nausea
Decreased motility
Fecal impaction and constipation
Gastrointestinal atony or ileus
Myxedema or toxic megacolon—late
Neurogenic oropharyngeal dysphagia
ileus
Neurological
Altered mentation
Coma
Confusion and obtundation
Delayed tendon reflexes
Depression
Poor cognitive function
Psychosis
Seizures
Renal and urinary function
Bladder dystonia and distension
Fluid retention
Appearance and dermatological
Alopecia
Coarse, sparse hair
Dry, cool, doughy skin
Myxedematous face
Generalized swelling
Goiter
Macroglossia
Non-pitting edema
Ptosis
Periorbital edema
Surgical scar from prior thyroidectomy
HypothermiaLaboratory features in myxedema coma:
Anemia
Elevated creatine kinase (CPK)
Elevated creatinine
Elevated transaminases
Hypercapnia
Hypercholesterolemia (elevated LDL)
Hyperlipidemia
Hypoglycemia
Hyponatremia
Hypoxia
Leukopenia
Respiratory acidosis

Epidemiology
Hypothyroidism is four times more common in women than men. The incidence of myxedema coma has been reported to be 0.22 per 1000000 per year but the data is limited and especially lacking in countries outside the western world and countries along the equator. Myxedema coma is most common in people 60 years old and older and is most common in the winter months when hypothermia is more common. See also
Thyroid storm
Euthyroid sick syndrome

References


== External links ==